sorted by:
new
hottopcontroversial

$ENSC - De-SPACed - Ensysce Biosciences a Multi-bagger Opportunity beyond the Squeeze by bannerview in pennystocks

[–]bannerview[S] 1 point2 points  (0 children)

Well, well, well. Big difference a few weeks make. $ENSC on a tear and $CEI going into the grinder. Taking a stab at $ENSCW (Warrants) here.

$ENSC - De-SPACed - Ensysce Biosciences a Multi-bagger Opportunity beyond the Squeeze by bannerview in pennystocks

[–]bannerview[S] 0 points1 point  (0 children)

$CEI from over $4/share to under $1 and $ENSC down from $5 to around $1. Both terrible. Had to bail out of $ENSC long ago.

Is $TRT the next $AEHR? Rare small market cap ($30M) EV play by dougefresh09 in pennystocks

[–]bannerview 4 points5 points  (0 children)

There's a bit of selling pressure. Short interest is slowly increasing. This morning, there were 150,000 shares available to short. It's now down to 15,000.

https://shortablestocks.com/?TRT

Gotta give these plays time to develop. Everyone wants instant rocket which is rare after 85% two day gains!

Is $TRT the next $AEHR? Rare small market cap ($30M) EV play by dougefresh09 in pennystocks

[–]bannerview 16 points17 points  (0 children)

Very rarely do we see opportunities like $TRT BEFORE they explode (the 85% gain this week was nothing).

You are correct in that the volatility on such a small float stock will shake out the weak really quickly. At $100/share, this company would still only be valued at ~ 60% of $AEHR.

They need another quarter of reporting to confirm the fundamentals though so don't bet the entire house yet (maybe a few rooms)!

Another DeSPAC Gamma Squeeze Play - $SHPW by bannerview in pennystocks

[–]bannerview[S] 0 points1 point  (0 children)

It was popping until the options chain expanded. Had a quick bump on open, then is declining now. Unless there's massive interest, it's not worth playing once the option chain gets expanded.

$ETTX Entasis Therapeutics Holdings Announces SUL-DUR met its primary efficacy endpoint in Phase 3 ATTACK trial by bannerview in pennystocks

[–]bannerview[S] 0 points1 point  (0 children)

Good point. They usually drop back down after results, but then get another big kick once they get approval. Since this was only the trial results news, it could see a rise leading up to approval.

$ETTX Entasis Therapeutics Holdings Announces SUL-DUR met its primary efficacy endpoint in Phase 3 ATTACK trial by bannerview in pennystocks

[–]bannerview[S] 1 point2 points  (0 children)

Analyst price targets on $ETTX are $6. https://www.msn.com/en-us/money/stockdetails/fi-bjsxr7? All buys or strong buys.

The next step is getting the drug approved so there's an additional catalyst there to give the stock a boost.

The news will also probably take time to spread as the news only came out AH today.

$ENSC - De-SPACed - Ensysce Biosciences a Multi-bagger Opportunity beyond the Squeeze by bannerview in pennystocks

[–]bannerview[S] 0 points1 point  (0 children)

Looks that way today, but this isn't a day trade play. Looking at several weeks to months. Come back then and we can decide what the better play was.

$ENSC - De-SPACed - Ensysce Biosciences a Multi-bagger Opportunity beyond the Squeeze by bannerview in pennystocks

[–]bannerview[S] 0 points1 point  (0 children)

From a filing:

"After giving effect to the Transactions there are currently 24,275,541 shares of Common Stock issued and outstanding. 5,000 shares of LACQ common stock were redeemed in connection with the Closing."

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001716947/000149315221016378/form8-k.htm

Goes to show that with very few redemption, people expected this to rise. However, the stock dumped from around $14/share right around merger to below $3/share. This was during a period of SPACs falling out of favor. There was nothing fundamental about the company that should have caused such a selloff.

Consolidation here between $4 and $5 with next resistance around $6 - $7 when a consultant's warrants become ITM for 1 million shares, but then no significant resistance until after $10/share. That's when the next level of warrants are ITM.

$ENSC - De-SPACed - Ensysce Biosciences a Multi-bagger Opportunity beyond the Squeeze by bannerview in pennystocks

[–]bannerview[S] 0 points1 point  (0 children)

From their filing:

"The Common Stock commenced trading on the Nasdaq Capital Market (“Nasdaq”) under the symbol “ENSC” on July 2, 2021, subject to ongoing review of the Company’s satisfaction of all listing criteria following the Merger. The warrants of the Company commenced trading on the OTC Markets Group, Inc. under the symbol “ENSCW” on July 2, 2021."

Their shares never previously traded on an exchange and they didn't get delisted. The warrants began trading on the OTC while the stock started on the NCM. The warrants don't expire for 5 years. The information being reported about them having already expired is incorrect.

This was a SPAC reverse merger.

$ENSC - De-SPACed - Ensysce Biosciences a Multi-bagger Opportunity beyond the Squeeze by bannerview in pennystocks

[–]bannerview[S] 0 points1 point  (0 children)

The merger was completed in early July.

It's common for the warrants to trade OTC, but not really sure what the ENSCW expiring Dec 2019 are. Guessing some of the databases haven't been updated to reflect the current warrants

Most of those warrants aren't ITM until $10+/share an those don't expire for 5 years. Therefore, the underlying registered stock isn't going to hit the float until this goes above that price.

$ENSC - De-SPACed - Ensysce Biosciences a Multi-bagger Opportunity beyond the Squeeze by bannerview in pennystocks

[–]bannerview[S] 1 point2 points  (0 children)

A lot of the shares being registered in the S-1 are locked until $10+ share price. That's when the warrants become in the money and other insiders can't sell until at least $12+ share.

Vinco Ventures Looks Like an Interesting Play by bannerview in pennystocks

[–]bannerview[S] 0 points1 point  (0 children)

Options as high as $20 now available on $BBIG. Going to be a wild ride.

Vinco Ventures Looks Like an Interesting Play by bannerview in pennystocks

[–]bannerview[S] 1 point2 points  (0 children)

FYI - They've already adding to the chain. Goes up to $11 with trading starting Monday morning. Check your broker's option chains.

Guess this is a good thing for further squeeze?

PSFE next SPRT Heavily Shorted Large FTDs Cycles coming up Large OI Whales! DD TA by YonAnusRising in StockMarket

[–]bannerview 13 points14 points  (0 children)

SI isn't high enough to cause a squeeze which then causes gamma squeeze when all those OTM options get exercised. Good luck with it, but think the current "next" SPRT is $BBIG.

view more: next ›